XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Clinical trial NCT01582295 · COMPLETED
Trial details
- NCT number
- NCT01582295
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.